Porcine Circovirus Type 3 (PCV3) Vaccines, and Production and Uses Thereof
AssigneesBoehringer Ingelheim Vetmedica GmbH, Iowa State University Research Foundation, Inc.
InventorsArun IYER, Luis Alejandro Hernandez, Abby Patterson, Bailey Arruda, Luis Gabriel Gimenez-Lirola, Dave Michael Anstrom, Eric M. Vaughn, Pablo E. Pineyro Pineiro, Troy James Kaiser, Joseph Ralph Hermann
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of an immunogenic composition that comprises a porcine circovirus type 3 (PCV3) antigen for treatment of several clinical manifestations (diseases). Preferably, the clinical manifestations are associated with a PCV3 infection.
Claims21
1-141. (canceled)
An immunogenic composition for inducing an immune response against PCV3 infection in a pig comprising a porcine circovirus type 3 (PCV3) ORF2 protein.
A composition comprising a (i) porcine circovirus type 3 (PCV3) ORF2 protein, a parvovirus (PPV) protein and optionally a PRRSV (porcine respiratory and reproductive syndrome virus) protein and (ii) a veterinary-acceptable carrier selected from the group consisting of a solvent, a dispersion media, a coating, a stabilizing agent, a diluent, a preservative, an antimicrobial agent, an antifungal agent, an isotonic agent, an adsorption delaying agent, an adjuvant, cell culture supernatant, a stabilizing agent, a viral vector, an expression vector, and an immunomodulatory agent, or any combination thereof.
Dependencies are inferred from the claim text.